Table 3. Antimicrobial susceptibility of the recovered isolates.
| Antibiotic class | Antibiotic | E. coli (n=24) | S. aureus (n=21) | ||||
|---|---|---|---|---|---|---|---|
| S (%) | I (%) | R (%) | S (%) | I (%) | R (%) | ||
| Penicillin | AMX | 2 (8.3) | 2 (8.3) | 20 (83.4) | 3 (14.2) | 0 (0) | 18 (85.8) |
| AMC | 3 (12.5) | 6 (25.0) | 15 (62.5) | 3 (14.2) | 3 (14.2) | 14 (66.6) | |
| OXA | 6 (25.0) | 5 (20.8) | 13 (54.1) | 2 (9.6) | 0 (0) | 21 (100) | |
| Cephalosporin | CAZ | 0 (0) | 6 (25.0) | 18 (75.0) | 5 (23.8) | 0 (0) | 16 (76.2) |
| CTR | 4 (16.6) | 0 (0) | 20 (83.4) | 9 (42.9) | 3 (14.2) | 9 (42.9) | |
| FOX | 6 (25.0) | 6 (25.0) | 12 (50.0) | 2 (9.6) | 0 (0) | 21 (100) | |
| Fluroquinolones | NOR | 12 (50.0) | 7 (29.2) | 5 (20.8) | 14 (66.6) | 0 (0) | 7 (33.4) |
| Monobactam | ATM | 14 (58.4) | 6 (25.0) | 4 (16.6) | 13 (62.0) | 3 (14.2) | 5 (32.8) |
| Aminoglycoside | AK | 16 (41.6) | 8 (33.4) | 0 (0) | 19 (90.4) | 1 (4.7) | 1 (4.7) |
| GEN | 18 (75.0) | 0 (0) | 6 (25.0) | 10 (47.6) | 6 (28.6) | 5 (32.8) | |
| Carbapenem | MEM | 21 (87.5) | 3 (12.5) | 0 (0) | 21 (100) | 0 (0) | 0 (0) |
| Nitrofuran | NIT | 20 (83.4) | 3 (12.5) | 1 (4.1) | 15 (71.4) | 3 (14.2) | 0 (0) |
| Tetracycline | DOX | 8 (33.4) | 6 (25.0) | 10 (41.6) | 9 (42.9) | 3 (14.2) | 9 (42.9) |
| Sulfonamide | SXT | 12 (50.0) | 0 (0) | 12 (50.0) | 10 (47.6) | 0 (0) | 11 (52.4) |
| Mean ± SE | 10.14a±1.860 | 4.143a±0.7402 | 9.714a±1.908 | 9.643a±1.663 | 1.571a±0.5105 | 9.786a±1.962 | |
Asignificant difference at p < 0.0001; AMX: Amoxicillin; AMC: Amoxicillin and clavulanic acid; OXA: Oxacillin; CAZ: Ceftazidime; CTR: Ceftriaxone; FOX: Cefoxitin; NOR: Norfloxacin; ATM: Aztreonam; AK: Amikacin; GEN: Gentamicin; MEM: Meropenem; NIT: Nitrofurntin; DOX: Doxycycline; SXT: Trimethoprim-sulfamethoxazole.